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ABSTRACT 
Sir John Cornforth’s work on the stereochemistry of enzyme reactions involved in the biosynthesis of 
squalene and cholesterol and in the formation and metabolism of a chiral methyl group in acetyl co-
enzyme A, is reviewed. 
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1. Introduction 
In December 1953, Sir Robert Robinson began his famous Weizmann Memorial lectures on The 
structural relations of natural products1 with the sentence: “Organic chemists have often been 
tempted to leave the security of their own proper pastures and to graze, albeit speculatively, in the 
alternative fields of biochemistry.” Sir John Cornforth, in collaboration with biochemists, devised 
experiments with results that addressed significant aspects of that speculation. In 1947, Sir Robert 
Robinson had been awarded the Nobel Prize for his investigations on plant products of biological 
importance and in 1975 his pupil, Sir John Cornforth, was awarded the Nobel Prize for his work on 
the stereochemistry of enzyme reactions. 
There have been a number of stages in the study of the biosynthesis of natural products. The first 
period, prior to the Second World War, was primarily speculative in which the analysis of the 
structures and co-occurrence of natural products led to the proposal of common building blocks and 
structural relationships. The second period, which developed after the Second World War and 
extended into the 1960s, involved the experimental identification of these building blocks and the 
sequences which inter-related natural products. The third period, which began in the 1950s and has lasted 
to the present, has involved the elucidation of the stereochemistry and mechanism of these 
processes. This has led to the identification and isolation of the enzyme systems that mediate key 
biosynthetic steps and more recently, to an understanding of the genetics that control these steps. Sir John 
Cornforth’s contributions to our understanding of the stereochemistry of enzyme reactions fall into the 
second and third stages and were carried out mainly in the period from 1948. 
A number of features contributed to the development of this work. In 1948, A.G. Ogston pointed 
out2 that when a molecule with the structure Caabc 1 having two identical groups ‘a’ attached to a 
carbon atom, binds to the chiral cavity of an enzyme system using a three-point binding of the 
groups a,b,c, the originally identical groups ‘a’ are differentiated, i.e. the chirality of the enzyme 
system is reflected in a pro-chirality of the molecule Caabc and in particular of the groups ‘a’. At the time 
this led to an understanding of the distribution of radioactivity in citric acid 2 metabolism. Cornforth not 
only realised that this had much wider implications in biosynthesis but he was also able to return to the 
citric acid system later in his career. 
The increasing post-war availability of the isotopes of carbon and hydrogen and the techniques for 
measuring them meant that many biosynthetic experiments which had previously relied on changes in 
the quantities of metabolite production to demonstrate precursor:metabolite relationships, could be 
examined with greater confidence3. From 1948 at the National Institute for Medical Research, Sir John 
 I 
Cornforth was able to work with a biochemist, George Popják. This collaboration continued when 
they moved to the Milstead Laboratory of Chemical Enzymology, Sittingbourne, Kent, run by Shell. 
When Popják went to the University of California, Los Angeles in 1968, Cornforth began a collaboration 
with Professor Hermann Eggerer, a biochemist at the Institut für Biochemie der Universität München. 
Whereas Cornforth’s research with Popják was mainly on squalene and sterol biosynthesis, his 
studies with Eggerer involved the chiral methyl group in which two of the hydrogen atoms were 
stereospecifically replaced by deuterium (2H) and tritium (3H). 
2. The biosynthesis of cholesterol 
2.1 The background 
The sterols, the bile acids and the steroid hormones have many biological roles and consequently an 
understanding of their biosynthesis was of considerable importance. It has subsequently been shown that 
a number of major drugs such as the statins affect their biosynthesis. Having been concerned with the 
total synthesis of cholesterol, it was not surprising that Cornforth turned his attention to sterol 
biosynthesis. His work involved locating the position of the simple biosynthetic building blocks in the 
sterols and their precursors and then establishing the stereochemistry and mechanism of the biochemical 
processes by which they were assembled. This entailed not only the synthesis of the specifically labelled 
biosynthetic precursors but also a careful analysis of their metabolites to determine the eventual site of the 
labels. 
There were a number of antecedents to Cornforth’s work in this area. In 1922, Ruzicka had 
proposed4 that terpenoids were assembled by the head-to-tail linkage of C5 isoprene units. When 
the structures of squalene 4 and cholesterol 6 were established, it was clear that they fell into this family 
of natural products. In 1934, Robinson developing an earlier proposal by Channon that squalene was a 
precursor of cholesterol, suggested5 a folding 5 of squalene to generate the carbon skeleton of the 
sterols. The subsequent elucidation of the structures of the tetracyclic triterpenes such as lanosterol, 
led R.B. Woodward in 1953 to propose6 an alternative folding of squalene 7. 
2.2 The acetate labelling pattern of cholesterol 
Experiments by Rittenberg and Schoenheimer in 1937 and by Bloch and Rittenberg in 1942 had 
established7 the incorporation of [2H3]-acetate into cholesterol. Degradative experiments reported8 
by Bloch in 1952 identified the labelling pattern of the side chain from the methyl and carboxyl 
groups of [14C]-acetate. However, establishing the labelling pattern of the tetracyclic carbon skeleton 
was a more difficult problem. Cornforth with his experience of steroid synthesis, rose to the challenge. 
Popják carried out the biochemical work by feeding separate samples of, on the one hand [14C-carboxyl] 
and on the other [14C-methyl]-labelled  acetate 3, to rat liver slices. He was able to obtain a sufficiently 
high incorporation (2.5–3%) into cholesterol to facilitate Cornforth’s chemical studies9. Despite the 
extensive known chemistry of cholesterol, the unambiguous identification of each carbon atom in 
this part of the molecule required the development of novel strategies10,11 to dismember the tetracyclic 
ring system. These involved ozonolysis of alkenes in rings B and D and then the stepwise degradation of 
the resulting aldehydes and ketones in order to isolate the individual carbon atoms in a form whose 
radioactivity could be measured. The results of this work established the labelling pattern of 
cholesterol 6. Degradation of squalene, again involving ozonolysis, showed12 that it possessed the 
labelling pattern as shown in 4.  Taken together, these pieces of work defined the way in which squalene 
is folded to form cholesterol as 7 (the Woodward scheme, note the origin of the carbon atoms of ring C). 
Although the cyclisation was originally formulated as involving [OH+], it is now known to proceed via 
the 2,3-epoxide and it is not completely concerted. 
 Almost incidental to this work but, nevertheless, of great importance, was the correlation of the 
degradation product from ring D with (+)-citronellal which served to establish the absolute 
stereochemistry of cholesterol13. 
2.3 The role of mevalonic acid 
The elucidation of the role of mevalonic acid 8 in the biosynthesis of terpenoids and steroids was 
based on the discovery14 in 1956 by Tavormina, Gibbs and Huff that the Lactobacillus casei growth factor 
(-hydroxy--methyl-δ-valerolactone, mevalonic acid lactone 9) was a precursor of cholesterol15. 
Cornforth prepared [2-14C]-mevalonic acid lactone by a Reformatski reaction between methyl [2-14C]- 
bromoacetate and 1-acetoxybutan-3-one and, in 1957, he was able to show16,17 that it was also a precursor 
of squalene. This paved the way for his important series of experiments on the stereochemistry of 
squalene, and consequently cholesterol, biosynthesis. 
2.4 The stereochemistry of squalene biosynthesis 
Although the C30 squalene is a symmetrical molecule, its enzymatic formation from six mevalonic 
acid units involves a number of stereospecific processes. Various workers such as Lynen in 
Germany18 and Bloch in the USA19 had shown that the C6 mevalonic acid 8 was converted into a C5 
compound, isopentenyl diphosphate 11, which formed the isoprene unit from which the terpenes and 
steroids were constructed. Isopentenyl diphosphate underwent isomerisation to 3,3-dimethylallyl 
diphosphate 10 and, on combination with further isopenteny1 diphosphate units, this formed firstly 
the C10 geranyl diphosphate 12 and subsequently the C15 farnesyl diphosphate 13, two molecules of 
which were linked together to form squalene. Cornforth investigated the stereochemistry of these steps in 
studies which represent the transition from experiments to define the nature of the basic building blocks 
of sterol biosynthesis, to experiments which were designed to examine the stereochemistry and possible 
mechanisms by which these building blocks were assembled to form the sterols. 
In a logical dissection of squalene biosynthesis from mevalonic acid, Cornforth identified20 14 
steps at which asymmetric labelling of precursors might uncover stereospecificity in the enzyme 
reactions. If each of these steps could proceed in one of two stereochemical senses, there would be 214 or 
16,384 possible routes to be distinguished. These biosynthetic questions included the following: 
• When mevalonic acid 8 as its 5-diphosphate is converted into isopentenyl diphosphate 11, 
is the elimination of the C-3 hydroxyl group and the carboxyl group a cis or a trans process? 
• When isopentenyl diphosphate 11 is isomerised to 3,3-dimethylallyl diphosphate 10, to 
which face of the double bond is the new proton added, and which of the two hydrogens at 
C-2 is lost and, consequently, is the new methyl group cis or trans to the C-1 diphosphate? 
• In the reaction of 3,3-dimethylallyl diphosphate 10 with isopentenyl diphosphate 11 to form 
the C10 geranyl diphosphate 12, which side of the double bond of the isopentenyl diphosphate 11 
is attacked by the 3,3- dimethylallyl diphosphate 10, and what is the stereochemistry of the 
hydrogen which is eliminated from C-2 of the isopentenyl diphosphate 11 to create the new 
alkene in geranyl diphosphate 12? 
• When the new C–C bond is formed in this step, does this take place with inversion or 
retention of configuration at C-1 of the allylic diphosphate 10? 
• An identical set of questions was formulated for the conversion of geranyl diphosphate 12 to 
farnesyl diphosphate 13.  
When two molecules of farnesyl diphosphate 13 are combined in a head-to-head manner to form 
squalene 4, it was found that one hydrogen from C-1 of one of the farnesyl diphosphate units was 
 replaced by hydrogen from NADPH. What was the stereochemical origin of this hydrogen on the 
NADPH and what was its fate, and finally what changes were there to the configuration at C-1 of the 
other molecule of farnesyl diphosphate 13? 
The investigation of these points required the synthesis of stereospecifically labelled mevalonates21. 
2.5 The synthesis of stereospecifically labelled mevalonates 
The use of the stereospecifically deuterated and tritiated mevalonates in the study of sterol biosynthesis, 
rests on the fact that only the (3R) isomer of mevalonic acid 8 acts as a substrate for the first enzymatic 
step, the mevalonate kinase, i.e. the (3S)-mevalonate isomer in a racemic mixture is essentially a 
‘spectator’ in the biosynthetic pathway. The strategy for introducing the label at C-4 with a 
stereospecifically defined relationship to the tertiary alcohol at C-3 depended on the reduction of a 3,4-
epoxide by a hydride reagent which proceeded in a trans manner. The preparation22 of the (4R) and 
(4S)-[4-2H or 4-3H] mevalonic acids utilised, in separate experiments, the lactone 14 with a cis 
double bond and the trans hydroxy-acid 16. Their epoxides were reduced with lithium [2H or 3H]-
borohydrides to give the labelled mevalonic acids 15 and 17, respectively, in which there was a trans 
relationship between the hydroxyl group at C-3 and the newly introduced deuterium or tritium isotope 
at C-4. By interconverting the carboxyl and primary alcohols of mevalonic acid, the chirality of the label 
which had been introduced at C-4, was transferred to C-2, to generate the (2S) and ( 2R)-labelled 
mevalonates23. 
Cornforth prepared24,25 (5-2H2)- and  (3RS,5S)-[5-3H1]-mevalonic acids by chemical and chemo-enzymatic 
methods, respectively.  A stereospecific label at C-5 may also be introduced by the enzymatic reduction 
of mevaldic acid 18 → 19 using mevaldate reductase and labelled NADH or NADPH as coenzyme. 
[5-18O]-Mevalonolactone was prepared by the acid-catalysed hydrolysis of the dimethylacetal of methyl 
mevaldate with [18O]-water followed by reduction with sodium borohydride26. A synthesis of (3R) and 
(3S)-mevalonolactone from the epimers (+)-linalool and (–)-linalool (20) led27 to a correction of the 
stereochemical assignment to the latter. 
2.6 The biosynthesis of farnesyl diphosphate 
The fate (23 → 24) of these stereospecific labels when the mevalonates were used as substrates for 
biosynthesis provided many answers to the stereochemical questions which Cornforth had posed. The 
stereochemistry of the hydrogen atoms at C-2 of isopentenyl diphosphate (corresponding to C-4 of 
mevalonic acid) that were lost in the formation of 3,3-dimethylallyl diphosphate and in the chain 
elongation steps, was established22 by incubating both (4R)- and (4S)-[4-2H]- mevalonates with rat 
liver slices. Analysis of the resultant farnesyl diphosphate with its trans double bonds, showed that 
only three (4R)-deuterium atoms were retained whilst the (4S)-deuterium was lost. In contrast, when 
rubber with its cis double bonds is formed, it is the pro-(4R)-mevalonoid hydrogen atom which is 
lost. 
The geometry of the ( 2R)- and ( 2S)-[2H]-mevalonoid  labels in the isopentenol derived from 
isopentenyl diphosphate showed23 that there was a trans elimination of the carboxyl and the C-3 
hydroxyl group of mevalonic acid, in the formation of isopentenyl diphosphate. However, the 
identification of the face of this alkene which was protonated in the isomerisation to 3,3-
dimethylallyl diphosphate, had to wait until the stereochemistry of chiral methyl groups could be 
elucidated. 
The stereochemistry of the carbon–carbon bond formation in the homologation steps was 
 established24 by using a sample of ( 5R)-[5-2H]-mevalonate  to give farnesyl diphosphate. Degradation 
of this gave [2H]-succinic acid 21 in which the methylene groups represent C-1 and C-5 of two 
separate isoprene units. Cornforth had access to a very sensitive polarimeter with which to measure 
the small changes in optical rotation with wavelength (optical rotatory dispersion) arising from the 
chiral replacement of hydrogen by deuterium. Optical rotatory dispersion measurements showed that 
this was (R)-[2H]-succinic  acid arising from an inversion of configuration at the terminal position 
of the allylic diphosphate in the formation of the new C–C bonds. 
2.7 The formation of squalene 
The formation of squalene from two molecules of farnesyl diphosphate has turned out to be more 
complex28-31 than originally thought. When squalene was biosynthesised by a rat liver enzyme using [5-
2H2]mevalonate as a substrate, eleven out of the possible 12 deuterium atoms were incorporated. One 
label was lost from the central two carbon atoms of squalene. Ozonolysis of the squalene produced 
biosynthetically from this mevalonate gave a trideuteriosuccinic acid which was shown to have an 
(S)-configuration. When (R)-[1,5,9-2H3]farnesyl diphosphate, prepared from (5R)-]5-2H]mevalonate, was 
used as a substrate, there was no loss of label in the formation of the squalene. Furthermore, ozonolysis 
of the squalene gave an optically inactive meso (RS)-isomer of dideuteriosuccinic acid. Thus there was an 
overall retention of configuration at C-1 of one molecule of farnesyl diphosphate and an inversion of 
configuration at the other. The hydrogen that was introduced into the formation of squalene had its 
origin in NADPH. 
Nicotinamide adenine dinucleotide and its phosphate (NAD and NADP) are the co-enzymes for a 
large number of enzyme-catalysed hydrogen transfer reactions. The hydrogen can be transferred to 
and from either of the faces of the dihydropyridine ring 22 depending on the particular enzyme. These 
enzymes were known as ‘A’ or ‘B’ enzymes but the absolute stereochemistry of the hydrogen transfer 
was unknown. Cornforth prepared32 enzymatically  ‘A’ and ‘B’ samples of NAD2H specifically 
labelled on each of the C-4 hydrogens of the pyridine ring. Degradation of these samples to the 
corresponding [2H]succinic acid and determination of their absolute stereochemistry from their 
optical rotatory dispersion, showed that the ‘ A’ face enzymes transferred the pro-R hydrogen and 
the ‘B’ face enzymes transferred the pro-S hydrogen. It was the latter that provided the hydrogen 
which was introduced into squalene during the linking of the two molecules of farnesyl 
diphosphate33. Subsequent work revealed the intermediacy of pre-squalene phosphate providing an 
explanation for the replacement of the mevalonoid hydrogen by one from NADPH. A hydrogen 
atom is lost from one molecule of farnesyl diphosphate in forming the cyclopropane ring of 
presqualene diphosphate whilst a hydrogen atom is introduced from NADPH during its subsquent 
conversion to squalene. 
2.8 The methyl group rearrangement in cholesterol biosynthesis 
During the biosynthesis of cholesterol a methyl group (C-18) becomes attached to C-13. The 
initial cyclisation of squalene would give an intermediate bearing methyl groups at C-8 and C-14. 
One of these methyls is lost (from C-14) in the formation of cholesterol whilst the other becomes 
attached to C-13. This could arise by two 1,2-methyl group migrations from C-8 to C-14 and from C-14 
to C-13 or by a single 1,3-methyl group rearrangement from C-8 to C-13 leaving the group 
originally at C-14 to be lost.  Cornforth devised34 an elegant experiment to distinguish between these 
possibilities. The methyl group rearrangement from C-14 to C-13 takes place within a single isoprene 
unit and the methyl group becomes attached to a carbon that had originally been C-4 of mevalonate. On 
the other hand, a 1,3-methyl group rearrangement between C-8 and C-13 takes place between two 
 separate isoprene units. In order to study this, Cornforth prepared [3′,4-13C2]mevalonic acid 25. 
This mevalonate which was suitably diluted with unlabelled mevalonate so that when it was used in a 
biosynthesis  the adjacent isoprene units were not labelled. Degradation of the resultant cholesterol 26 
gave [13C2]acetic acid 27 derived from C-13 and C-18, showing that the rearrangement had involved a 
1,2-shift within an isoprene unit. 
Cornforth’s strategy of using stereospecifically labelled mevalonates in squalene and cholesterol 
biosynthesis provided the stimulus for other workers to carry out numerous experiments to unravel the 
stereochemistry of the later stages of terpenoid and steroid biosynthesis. Apart from steroid biosynthesis, 
these have included the stereochemistry of cyclisation, hydroxylation, desaturation and ring-contraction 
reactions in sesquiterpenoid, diterpenoid and carotenoid biosynthesis. 
3. The chiral methyl group35 
3.1 The background 
If each of the hydrogen atoms of a methyl group are stereospecifically labelled with the isotopes, 
protium, deuterium and tritium, the methyl group becomes chiral. The formation and fate of such a 
methyl group in a biochemical system can shed a light on the stereochemistry of the enzyme 
reactions that are involved. Thus there are a number of enzyme-mediated reactions in which a 
methyl group is generated from a methylene. These include the protonation of the methylene of an 
alkene as in the isomerisation of isopentenyl diphosphate 11 to 3,3-dimethylallyl diphosphate 10. 
Another set of enzyme reactions involve the replacement of a leaving group by hydrogen as in the 
formation of acetyl co-enzyme A by the decomposition of citric acid. In the first set of enzyme reactions 
there is a stereochemical question concerning the face of an alkene which is protonated by the enzyme to 
generate the methyl group whilst in the second case the incoming hydrogen from the enzyme can replace 
the leaving group with retention or inversion of configuration. In each case, if the methylene is 
stereospecifically labelled with deuterium and tritium, a chiral methyl group may be generated by the 
addition of protium. 
In the reverse situation, a methylene may be generated from a methyl group. For example, a 
hydrogen of the methyl group of acetyl co-enzyme A may be substituted by another group. The 
hydrogen may be replaced with retention or inversion of configuration. However, since a methyl 
group can freely rotate, the discrimination between these processes is based on the primary isotope effect 
in which replacement of a hydrogen atom will be favoured over a deuterium or tritium. Comparison of the 
absolute configuration of the deuterium and tritium in the resultant methylene with the chirality of the 
methyl group in the original acetyl co-enzyme A, will establish the overall stereochemistry of the process. 
3.2 The synthesis of the chiral methyl group in acetic acid 
Cornforth prepared35,36 chiral acetic acid containing protium, deuterium and tritium with a defined 
absolute configuration using reactions of established stereospecificity and a resolution. [2H]-
Phenylacetylene 28 was reduced with diimide, which adds hydrogen in a cis manner to the alkyne, to 
give (Z)-[2-2H]-1-phenylethylene 29. The epoxides (30, 31) of this alkene were then reduced with lithium 
[3H]-borohydride to give a mixture of (1R,2R) and (1S,2S)-[2-2H,2-3H]-1-phenylethan-1-ol (32, 33). This 
racemic mixture was then resolved to give the (1R) and (1S) enantiomers whose absolute configuration 
had been established by other studies. The reduction of the epoxide to generate these chiral alcohols 
related the absolute stereochemistry of the hydrogen isotopes in the methyl group to that of the alcohol. 
Oxidation of the chiral alcohols to the corresponding ketones followed by a Baeyer–Villiger oxidation 
gave the chiral acetic acids [34(R) and 35(S)]. 
 3.3 The assay of a chiral methyl group 
The method of assay of the chiral acetates depended on the known stereochemistry of two enzyme 
systems, malate synthase and fumarase. The first enzyme system produces (S)-malic acid 37 from 
acetyl co-enzyme A and glyoxalate 36, whilst the second enzyme system catalyses (reversibly) the 
trans dehydration of (S)-malic acid to fumaric acid. The isotope effect which favours replacement of 
hydrogen over deuterium from, for example, acetyl co-enzyme A produced from (R)-acetic acid 34, 
would generate an (S)-malic acid with an unequal distribution of the two isotopomers 37 and 38. 
Trans-dehydration by the fumarase in the first case would lead to a greater retention of tritium than 
in the second case (39 and 40 from 35), thus affording a distinction between the (R) and (S)-acetates. 
The assay was applied37 to the determination of the stereochemistry of protonation of isopentenyl 
diphosphate 42 to 3,3-dimethylallyl diphosphate 43. Earlier work had established the geometry of 
the tritium labels on the double bond of isopentenyl diphosphate when it was formed from (2R) 
and (2S)-[2-3H]mevalonates 41. Hence, when these mevalonates were used as substrates with an 
enzyme system operating in deuterium oxide, the resultant farnesyl diphosphate 44 possessed a chiral 
methyl group at the start of the chain which had arisen from the 3,3-dimethylallyldiphosphate. The 
farnesyl diphosphate was degraded and the sample of chiral acetate 45 was subjected to the assay. The 
results showed that the deuterium had been added to the re face of the alkene of isopentenyl diphosphate. 
This completed Cornforth’s stereochemical analysis of the pathway from mevalonate to squalene. 
3.4 Some applications of the chiral methyl group in biosynthetic experiments 
The study of the metabolism of citric acid has played a central role in understanding the 
biochemical pathways of primary metabolism. Cornforth applied the chiral methyl group to 
stereochemical investigations of a number of these enzyme reactions38-40. Although citric acid is a 
chemically symmetrical molecule, as Ogston has shown, the acetic acid arms are pro-chiral and, in 
the presence of enzyme systems such as citrate synthases and lyases, they are distinguishable. The 
si-citrate synthase and lyase catalyse the introduction and removal, respectively, of an acetyl co-enzyme 
A unit 46 to and from the carbonyl group of oxaloacetic acid 47 operating on one arm of citric acid 
48, whilst the re-synthase and ATP-citrate lyase operate on the other arm. Using samples of labelled citric 
acid which were cleaved by the si-citrate lyase in the presence of deuterium oxide to generate acetyl co-
enzyme A, Cornforth showed that this enzyme had operated with overall inversion of configuration. 
Succinic acid is also formed enzymatically from citric acid. The stereochemistry of the enzymatic 
dehydrogenation of the succinic acid to fumaric acid was used41 to establish the stereochemistry of 
samples of succinic acid obtained from citric acid and, in turn, that of the parent citric acid. By 
following the fate of the chiral labels in this sequence of enzyme reactions, Cornforth was able to show 
that the initial condensation between oxaloacetic acid and acetyl co- enzyme A to form citric acid, had 
also proceeded with inversion of configuration.  In the conversion of (S)-malic acid to pyruvic acid, 
Cornforth was able to show42 that the replacement of the carboxyl group by hydrogen occurred 
without an overall change of configuration. 
Cornforth then turned43 his attention to the formation of the mevalonic acid precursor, 3-hydroxy-3-
methylglutaryl co- enzyme A and to the chain elongation steps (49 → 52) of fatty acid biosynthesis44,45. 
For this he used the enantiomers of malonyl co-enzyme A 50 which, in fatty acid biosynthesis, is formed 
by the carboxylation of acetyl co-enzyme A. The overall results from Cornforth’s studies were that the 
carboxylation of the acetyl co-enzyme A occurred with retention of configuration whilst the condensation 
step in fatty acid biosynthesis proceeded with inversion of configuration. 
Cornforth’s work and parallel studies by Arigoni, paved the way for important stereochemical and 
 mechanistic studies by other workers involving acetyl co-enzyme A and the methyl group in biosynthesis. 
These included the stereochemistry of the biosynthetic reactions involving acetyl co-enzyme A in 
polyketide biosynthesis, the methyl transferases from S-adenosyl methionine, the methane mono-
oxygenases and rearrangements catalysed by the co-enzyme B12 such as the conversion of 2-
methylideneglutarate  to 3-methylitaconate46.Many of these studies were multi-national and Cornforth 
was able to make significant contributions to them. 
Cornforth’s pioneering and perceptive work on biosynthesis and, in particular, on the stereochemistry of 
enzyme reactions, has made immense contributions to the greater understanding that we have today of 
the chemistry that occurs within the active site of many key enzymes. Furthermore, the labelled 
substrates and methodology, which he developed, have been applied by many others and have had a 
major impact in replacing the speculation described by Robinson in the Weizmann lectures1, by 
experimental fact. 
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